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Abstract Alzheimer’s disease (AD) affects approximately
35 million people worldwide. Increasing evidence suggests
that many risk factors for AD are modifiable. AD pathology
develops over decades. Hence risk reduction interventions
require very long follow-ups to show effects on AD inci-
dence. Focussing on AD risk, instead of diagnosis, provides
a more realistic target for prevention strategies. We devel-
oped a novel methodology that yields a global approach to
risk assessment for AD for use in population-based settings
and interventions. The methodology was used to develop a
risk assessment tool that can be updated as more evidence
becomes available. First, a systematic search strategy iden-
tified risk and protective factors for AD. Eleven risk factors
and four protective factors for AD were identified for which
odds ratios were published or could be calculated (age, sex,
education, body mass index, diabetes, depression, serum
cholesterol, traumatic brain injury, smoking, alcohol intake,
social engagement, physical activity, cognitive activity, fish
intake, and pesticide exposure). An algorithm was devel-
oped to combine the odds ratios into an AD risk score. The
approach allows for interactions among risk factors which
provides for their varying impact over the life-course as
current evidence suggests midlife is a critical period for
some risk factors. Finally, a questionnaire was developed
to assess the risk and protective factors by self-report. Com-
pared with developing risk indices on single cohort studies,
this approach allows for more risk factors to be included,
greater generalizeability of results, and incorporation of
interactions based on findings from different stages of the
lifecourse.
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Given the long prodromal period for Alzheimer’s disease
(AD), the lack of effective treatments, and the increasing
prevalence associated with population aging, there is a need
to identify population health approaches to reducing risk of
the disease (Barnes et al. 2010). Information on risk factors
for Alzheimer’s disease is obtained from individual cohort
studies and meta-analyses of these studies. These studies
differ in terms of the number of exposures measured at
baseline, the length of follow-up and the sample character-
istics. Importantly, risk factors for AD may vary over the
adult life-course. In studies comprising only older adults,
there is potential confounding of the effects of preclinical
AD on risk scores. For example, body weight declines up to
6 years prior to AD diagnosis (Anstey et al. 2011), as does
serum cholesterol (Presecki et al. 2011). Cognitive decline
and brain changes occur many years prior to diagnosis yet
may be due to the disease and hence not independent risk
factors. Hence, no single study provides all the information
required for the development of an ideal risk assessment tool
for Alzheimer’s disease.
The aim of this study was to use an Evidence-Based
Medicine approach to develop a new approach to risk
assessment for Alzheimer’s disease that incorporates all
the currently reliable information on risk factors. This
methodology differs from that previously used to develop
risk assessment indices for dementia because it is based on
review of the extant literature, rather than analysis of a
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single cohort study. We chose to restrict the tool to risk
factors that could be assessed via self-report so that the
index can be implemented online in primary care and inter-
vention studies, and used in large-scale population health
programs. The methodology could potentially be used in
relation to other areas of chronic disease for which there is a
wide literature and need for long-term population-based
prevention strategies.
Previous Risk Assessment Indices for Alzheimer’s
Disease and Dementia
Two risk indices have been developed for AD specifically
(as opposed for the more general category ‘dementia’).
These have each been based on follow-up of a sample of
already older adults, to identify statistical associations be-
tween baseline measures and later diagnosis of AD. The first
was developed by Reitz et al. (2010) using data from the
Northern Manhattan study (n01051, mean age 75.66) and
includes sex, education, ethnicity, apolipoprotein E geno-
type, diabetes, hypertension, smoking, high density lipopro-
teins, and waist to hip ratio (Reitz et al. 2010). Despite its
strengths, this measure is not suitable for large-scale
population-based studies because it depends on clinical
assessment and genotyping. A second was developed from
a German Primary Care patient registry and involved fol-
lowing up 3055 patients three times, at 18-month intervals.
This study identified age, subjective memory complaint,
cognitive function, depressive symptoms and Instrumental
Activities of Daily Living (IADL) as predictors of conver-
sion to AD (Jessen et al. 2011). Ideally, a risk assessment
tool will not include screening measures or other indices of
current mild cognitive impairment (subjective memory
complaints, cognitive impairment, impairment in IADL) to
allow for separation of risk factors from the predicted
outcome. Mild cognitive impairment is often pre-clinical
AD (Lopez et al. 2007). As cognitive decline is a core
feature of dementia and AD, inclusion of cognitive function,
particularly indexed by a dementia screening instrument,
would mean the risk index is for use after cognitive decline
has commenced and hence is less predictive prior to the
onset of symptoms. The optimal risk assessment tool for
prevention trials will not include items that may also be
symptomatic of the disease.
Two risk indices for the broader diagnosis of dementia
(of which AD is the most common cause) have also been
reported in the literature. Kivipelto et al. developed a de-
mentia risk index using data from CAIDE study (n01449)
in 2006. They found that age, sex, education, hypertension,
high cholesterol and obesity predicted dementia risk over a
20-year follow-up period (Kivipelto et al. 2006). The par-
ticular strength of this index was the validation over a long
follow-up period and inclusion of middle-aged participants
in the baseline assessment; however, it was restricted to the
variables available in the baseline assessment of a single
study. A second dementia risk index was calculated using
data from the Cardiovascular Health Cognition Study (n0
3608, mean baseline age 76 years). In this study, age, poor
cognitive performance, low BMI, APOE genotype, white
matter hyperintensities on brain MRI, ventricular enlarge-
ment, thickening of the carotid artery, history of bypass
surgery, slow physical performance, and abstaining from
alcohol were risk factors for dementia over 6 years (Barnes
et al. 2009). This scale is not suitable for population-based
settings due to the inclusion of clinical measures. A brief
version of this second risk index has also been reported
(Barnes et al. 2010) and includes age, some simple cognitive
tests, self-report of attentional difficulties, stroke, peripheral
artery disease, coronary artery bypass surgery, low BMI,
and lack of alcohol consumption. Although this shorter
version requires less expensive clinical assessments, it still
requires cognitive assessment and detailed medical history
obtained from a health professional and is derived from a
single cohort study of older adults.
Previous dementia and AD risk indices were limited to
the variables included in the studies on which they were
based and to the characteristics of their cohorts such as age
at exposure (typically the age of the cohort at baseline
assessment). Hence, they do not take into account the fact
that some risk factors differ in their association with AD
over the adult life-course. For example, in mid-life both high
cholesterol and high BMI are risk factors for AD but in late-
life, neither is a risk factor for AD (Anstey et al. 2008,
2011). Moreover, some risk factors may also be affected
by the disease itself. Weight loss typically precedes AD by
about 6 years, and hence low BMI may show up as a risk
factor for AD in a study of older adults (e.g., Barnes et al.
2009) when it is actually as symptom of AD (Knopman et
al. 2007).
It is notable that the two previously published risk indices
for dementia described above found that opposite categories
of BMI were associated with increased risk of dementia.
This is a concrete example of the limitations of basing an
index on a single cohort, and the different findings resulting
from different baseline ages of the cohorts. Using the
broader data available from the literature on each risk factor
allows for inclusion of interactions between age and specific
risk factors to capture their differing effects over the adult
life course.
The present study aimed to develop a methodology for
creating a self-report Alzheimer’s Disease Risk Index that
could be updated as new findings become available. The
overall AD risk assessment tool was called the Australian
National University Alzheimer’s Disease Risk Index (ANU-
ADRI). There are three main advantages of this approach.
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First, it does not limit the possible number of risk factors
that may be included in the index. Second, it derives from
the principles of Evidence Based Medicine that assume the
most reliable estimates of effect sizes are obtained from the
statistical analysis of the population of studies (Davidoff et
al. 1995; Lyman and Kuderer 2005). Third, it allows for the
full information about a putative risk or protective factor to
be considered when designing the tool (e.g., the age of
exposure relevant to the risk factor, gender effects, optimal
measurement characteristics). This project builds on a series
of systematic reviews of risk factors for dementia and
Alzheimer's disease conducted by the authors (Anstey et al.
2007, 2008, 2009, 2011).
Method
There were four stages to the development of the ANU-ADRI
outlined in Fig. 1.
Development of a List of Putative Risk Factors
and Protective Factors for AD that Can Be Measured
by Self-report
The first stage (Fig. 1) involved collating an initial list of
possible risk factors for inclusion. This was collated from
the comprehensive review of risk factors for Alzheimer’s
Disease and Cognitive Decline published (Williams et al.
2010) and by the authors who had a thorough general
knowledge of the literature obtained when conducting pre-
vious systematic reviews (Anstey et al. 2007, 2008, 2009,
2011). A systematic search of review articles on risk factors
for AD, and review articles on risk factors for AD were
identified using PubMed search terms [Dementia OR
Alzheimer’s disease OR Cognitive impairment] AND
[Genetics, Age, Gender, Marital status, Family history of
dementia, Family history of AD, Body Mass Index,
Weight loss, Weight gain, Obesity, Occupation, Primary
occupation, Diabetes mellitis, Depression, Hyperlipidaemia,
Hypercholesterolemia, Cardiovascular disease, Myocar-
dial Infarction, Angina, Ischemic heart disease, Heart
failure, Cardiac failure, Arrhythmia, Atrial fibrillation,
Stroke, Cerebrovascular accident, Transient ischemic
attack, Hypertension, High blood pressure, Anxiety,
Smoking, Alcohol, Omega 3 intake, Fish consumption,
Physical activity, Exercise, Social network, Social en-
gagement, Social activities, Cognitive leisure activities,
Cognitive training, Brain training, Diet, Mediterranean
diet, Fruit and vegetable intake, Total caloric intake, Fat
intake, Caffeine, Antioxidants, Statin, anti-hypertensives,
Hypertension treatments, Hormone Replacement Therapy,
Oestrogen, Progesterone, NSAIDS, Vitamins, Nutritional
supplements].
The second stage involve selecting risk and protective
factors from the initial list for which there was reliable
evidence of an association with AD. Inclusion criteria were
that there was evidence for the risk factor derived from a
high quality meta-analysis or multiple high quality cohort
studies from which a pooled effect size could be calculated.
High quality studies and meta-analyses were defined using
the criteria applied in previous systematic reviews by the
authors (Anstey et al. 2007, 2008, 2009, 2011; Williams et
al. 2010). Briefly, they had to be prospective, have greater
than 100 subjects, more than 12 months follow-up, include
population-based samples and widely accepted research cri-
teria used to diagnose AD (e.g., DSM-IV criteria). Factors
for which high quality meta-analyses were available that
showed no significant association between the putative risk
Fig. 1 Flowchart showing stages of development of the ANU-ADRI
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factor and AD were excluded (e.g., hypertension, non-
steroidal anti-inflammatory drugs).
Selection of Odds Ratios for Inclusion in the AD Risk Index
In the third stage, the odds ratios associated with risk and
protective factors were derived from the literature using the
following hierarchy of methods. First, odds ratios were
extracted from systematic reviews where the exposure was
clearly defined. If odds ratios were not available from
systematic reviews, the authors identified high quality co-
hort studies and calculated odds ratios from pooled effect
sizes. This occurred for education, traumatic brain injury,
pesticide exposure, cognitive activity and social engagement
(available online). If odds ratios were available but the
exposure variable was not clearly defined in a manner that
could be translated into a self-report questionnaire, the orig-
inal and new high quality articles were located by authors and
new pooled estimates calculated by the authors (e.g., high
cholesterol and depressive symptoms) from articles reporting
exposures that were translatable. In the case of physical ac-
tivity, only one article contributing to the published pooled
estimate reported odds ratios that could be translated into a
measure and the results from this single article were used. In
the case of cognitive activity, we obtained the raw data from
authors and analysed it to determine cut-offs that could
meaningfully be linked to cutoffs on the questionnaire used
in these articles and then incorporated them into a self-report
questionnaire. Where possible data were stratified by age of
exposure, age of AD diagnosis, and sex.
Classification of Protective Factors
The ANU-ADRI includes both risk factors and protective
factors rather than rescoring all factors as ‘risk factors’
because this reflects the way factors have been portrayed
in the literature. Higher levels of physical activity, cogni-
tive activity and high intake of fish are included as pro-
tective factors while low level of social engagement is
included as a risk factor, consistent with the studies where
these original findings were reported (Fotuhi et al. 2009;
Fratiglioni et al. 2000; Williams et al. 2010; Wilson et al.
2007).
Selection of Questions for Inclusion in the AD Risk
Assessment Tool
In the fourth stage, definitions of exposure variables for
inclusion in the ANU Alzheimer’s Disease Risk Index were
determined. This led to the actual selection of questionnaire
items for inclusion in the assessment tool (available online).
Of risk factors identified for inclusion, the definitions of
exposure variables were identified from the descriptions
reported in articles reporting results of the relevant meta-
analyses in the first instance. However, for some risk fac-
tors, the descriptions of the measures of the risk factors were
not reported, but rather, generic categories created in the
process of pooling the data were used in analyses (e.g., low
physical activity versus high physical activity). In these
instances we searched individual articles included in meta-
analyses for exposure categories that could be linked to
actual questionnaire items.
Methodology for the ANU-ADRI Scoring System
Individual ANU-ADRI scores were developed by creating
an algorithm that sums the points attributed to individual
risk factors using a previously published method (Kivipelto
et al. 2006; Zammit et al. 2010). The points for each risk
factor were obtained from the standardized beta-weights
derived (from odds ratios of pooled effect sizes from meta-
analyses). The lowest beta co-efficient (0.13) was given a
score of one and other beta weights were standardized by
multiplying them by 1/0.1307.6923. An algorithm was
written that sums the points attributed to individual risk
factors (Kivipelto et al. 2006; Zammit et al. 2010) and
incorporates interactions with age for relevant risk factors
(high serum cholesterol, BMI) (Anstey et al. 2008, 2011).
Results
Thirty-eight potential risk factors were identified, of which
13 were excluded due to insufficient evidence. Of the 25
remaining risk factors, 6 were excluded because they
could not be assessed via self-report, and one (marital
status) was incorporated into a broader category of social
engagement in the actual measurement instruments. An-
other three risk factors were eliminated due to lack of
evidence of an association with AD. This left 11 risk
factors and 4 protective factors for inclusion in the ADRI.
Table 1 reports the actual points attributed to each risk
factor in the ANU-ADRI. Description of risk and pro-
tective factors and the source of effect sizes used in the
ANU-ADRI are described below.
Demographics Odds ratios for age and gender were derived
from population prevalence estimates of Alzheimer's disease
in Australia, Europe and the USA (Anstey et al. 2010; Jorm
et al. 2005; Access Economics 2009; Lobo et al. 2000;
Ritchie and Kildea 1995). A systematic review of 16 cohort
studies and 6 case control studies found a reliable associa-
tion between low education and risk of AD (n028025)
(Caamano-Isorna et al. 2006). However, this review com-
pared the lowest education group with the highest education
group, and the highest education group with any other level
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Table 1 Characteristics and sources of variables included in the ANU-ADRI
Characteristics Beta weight Points Source of β weight
Age for males
<65 years Reference 0 Anstey et al. 2010
65 years- 70 0.13 1 Jorm et al. 2005
70 years- 75 1.57 12 Access Economics 2009
75 years- 80 2.04 18 Lobo et al. 2000
80 years- 85 3.37 26 Ritchie and Kildea 1995
85 years- 90 4.24 33
>90 4.93 38
Age for females
<65 years Reference 0
65 years- 70 0.64 5
70 years- 75 1.87 14
75 years- 80 2.75 21
80 years- 85 3.71 29
85 years- 90 4.58 35
>90 years 5.28 41
Education
>11 years Reference 0 Launer et al. 1999. Karp et al. 2004
8 to 11 years 0.42 3
<8 years 0.80 6
BMI (age<60)




No diabetes Reference 0 Lu et al. 2009
Diabetes 0.33 3
Symptoms of depression
CES-D<16 Reference 0 Lenoir et al. 2004; Saczynski et al. 2010; Gatz et al. 2005;
Geerling et al. 2008; Dal Forno et al. 2005CES-D>16 Depression 0.29 2
High chol (aged<60)
Not high Reference 0 Anstey et al. 2008; Mielke et al. 2010; Solomon et al. 2009
High 0.41 3
TBI
No TBI Reference 0 Launer, et al. 1999; Plassman et al. 2000; Schofield et al. 1997
TBI 0.46 4
Smoking
Never Reference 0 Anstey et al. 2007
Ever smoking 0.19 1
Current 0.58 4
Alcohol intake
No alcohol Reference 0 Anstey et al. 2009
Light-mod -0.33 -3
Soc. engagement
Highest Reference 0 Fratiglioni et al. 2000; Saczynski et al. 2006
Lowest 0.84 6
Low to med 0.51 4
Med to high 0.17 1
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of education; hence, the results did not relate to categories
that were appropriate for the ANU-ADRI. We therefore
pooled data from four European studies reported in the
Eurodem analyses (Launer et al. 1999) and an additional
study from a more recent meta-analysis (Caamano-Isorna et
al. 2006; Karp et al. 2004) to produce the pooled estimate for
education. Marital status was included as part of a social
network measure described below and hence is not included
as a separate demographic variable.
Diabetes Diabetes was identified as a risk factor for AD in
a previous review (Williams et al. 2010). The odds ratio for
diabetes was obtained from a systematic review of 8 studies
(n023257) that identified diabetes mellitus by self report
plus use of anti-diabetic medications, or laboratory tests
(Lu et al. 2009; Williams et al. 2010).
Depression A meta-analysis of depression and AD (n0
102172) (Ownby et al. 2006) found that depression is a risk
factor for AD. In this meta-analysis depression was defined
according to diagnosis of depression or current symptoms
and measures of depression included a range of clinical
methods and scales, with validated cut-offs. In order to
identify an odds ratio for use in the ANU-ADRI, we inves-
tigated both history of depression, and depression measured
by symptom scales as a risk factor for AD because these
were both obtained by self-report. We re-analysed the data
from this meta-analysis and our review to pool four studies
reporting a history of depression (Gatz et al. 2005; Geerlings
et al. 2008; Li et al. 2001; Lindsay et al. 2002) and found
that self-reported history of depression was not associated
with AD. Of all symptom scales that could be administered
by self-report, the Centre for Epidemiological Studies
Depression Scale (CES-D 20-item scale) was included in
the greatest number of cohort studies reporting effect sizes
for the association between depressive symptoms and AD
reflecting the wide use of this measure in high quality
epidemiological studies. We therefore selected all studies
reporting associations between depression and AD where
depression had been measured using the CES-D from the
Ownby et al. meta-analysis, and also searched the literature
and identified two relevant studies that had been published
after this review was published. The effect size for depres-
sion as a risk factor for AD was computed from five studies
(Dal Forno et al. 2005; Gatz et al. 2005; Geerlings et al.
2008; Li et al. 2001; Lindsay et al. 2002) and the 20-item
CES-D was included in the ANU-ADRI.
Overweight BMI and Obesity Odds ratios for mid-life over-
weight BMI and obese BMI were obtained from our recent
meta-analysis of 15 cohort studies including 25624 partic-
ipants followed for AD. BMI categories were classified
using the WHO criteria (Sabia et al. 2009).
Brain Injury Our search of the literature identified traumatic
brain injury (TBI) as a potential risk factor for AD. Howev-
er, the only published meta-analysis reported a pooled esti-
mates for 15 case control studies including 4525 participants
(Fleminger et al. 2003). To obtain an estimate based on
prospective cohort studies, we identified three publications
Table 1 (continued)
Characteristics Beta weight Points Source of β weight
Physical activity
Lowest Reference 0 Scarmeas et al. 2009
Medium -0.29 -2
Higher level -0.40 -3
Cognitive activity




<0.25 p p/week Reference 0 Huang et al. 2005
0.25–2 p p/week -0.33 -3
2–4 p p/week -0.53 -4
>4 p p/week -0.62 -5
Pesticide exposure
Never Reference 0 Baldi et al. 2003; Hayden et al. 2010; Tyas et al. 2001
Ever 0.31 2
The points were derived by multiply the beta weights by 7.6923 and rounding up to an integer; TBI0 traumatic brain injury; soc.0social; p p/week0
portions per week
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reporting effect sizes for TBI as a risk factor for AD and
estimated a pooled effect size from these (Launer et al.
1999; Plassman et al. 2000; Schofield et al. 1997). The
forest plot for this analyses is included online.
Smoking Odds ratios for current versus never smokers, and
current versus former smokers were obtained from our pre-
vious meta-analysis of 19 prospective studies including
13786 participants followed for AD (Anstey et al. 2007).
Cholesterol Total serum cholesterol level in mid-life is rec-
ognized as a risk factor for AD (Anstey et al. 2008); how-
ever, studies vary in how the exposure variable is measured
and whether they use self-report or serum measures of high
cholesterol. For this study we updated our previously pub-
lished analyses and derived an odds ratio for self-reported
high cholesterol as a risk factor for AD based on the pub-
lished data for serum levels of cholesterol (National Insti-
tutes of Health 2002). We chose a cut-off of <6.2 (or less
than 240 mg/dl) for "normal" and >6.2 for high total cho-
lesterol based on recommendations from the Adult Treat-
ment Panel (ATP) III guidelines (National Institutes of
Health 2002) (Solomon et al. 2009). We estimated the odds
ratio from a meta-analysis that included the results from
articles included in our previously published systematic
review (Williams et al. 2010) as well as recently published
articles (Mielke et al. 2010; Solomon et al. 2009) and
involved follow-up data on 15780 participants (from 5 stud-
ies). The forest plot for this analysis is shown in the online
supplement.
Physical Activity There is consistent evidence that physical
activity reduces the risk of AD from meta-analyses (Hamer
and Chida 2009; Williams et al. 2010). However, no meta-
analysis of physical activity as a risk factor for AD reported
information on the exposure variables in a way that
could be translated into an available self-report measure
of physical activity. Hamer and Chida (2009) identified
only five studies reporting an association between phys-
ical activity and AD and only one of these incorporated
both intensity and frequency of physical activity (Laurin
et al. 2001). This study used questions that had not
been validated and were unsuitable for inclusion in the
ANU-ADRI.
On the basis that the literature does support the inclusion
of physical activity as a protective factor in the ANU-ADRI,
we decided to search for odds ratios from studies that
reported their findings in relation to specific measures of
physical activity that could be incorporated into a question-
naire. Given the aim of the ANU-ADRI for use in clinical
trials and to guide advice on risk reduction, we aimed to
include three levels of physical activity in the questionnaire,
and hence odds ratios needed to be available for medium
and high levels of physical activity compared to none. Only
one study was identified that reported odds ratios for levels
of activity that included a full range of categories and could
be translated into cut-offs on a questionnaire (Scarmeas et
al. 2009). Hence these odds ratios were selected. The
Scarmeas et al. (2009) study used the Gordin Leisure time
exercise questionnaire and this measure has shown a strong
association with the International Physical Activity Ques-
tionnaire (IPAQ) (Sandroff et al. 2012; Weikert et al. 2012).
Scarmeas et al. defined three levels of physical activity
using Metabolic Equivalent (MET). For the ANU-ADRI
we chose the IPAQ as a measure of physical activity because
it includes a more detailed assessment than the Gordin scale,
and unlike the Gordin scale has been validated in 12
countries ensuring greater generalizeability and validity of
the items (Craig et al. 2003). The ANU-ADRI point system
defines three levels of physical activity using MET values
according to the IPAQ scoring guidelines.
Alcohol Consumption Odds ratios for alcohol consumption
were obtained from our meta-analysis of 15 studies includ-
ing 14646 participants (Anstey et al. 2009). This review
showed that alcohol abstainers had an increased risk of
AD compared to light to moderate drinkers. In this review,
reference categories were based on those used in our meta-
analysis which corresponded to the current Australian
National Health and Medical Research Council categories.
In the ANU-ADRI, the AUDIT questionnaire is used to
assess the number of drinks per week and this instrument
provides the information required to generate the alcohol
consumption categories associated with the odds ratios
reported in our review.
Fish Consumption The only dietary factor reliably linked
to the risk of AD was fish consumption. This was found to
be protective against cognitive decline and AD (Barberger-
Gateau et al. 2007; Huang et al. 2005; Williams et al.
2010). A recent review of five cohort studies reported
that four showed a protective effect of fish intake or
long-chain omega-3 fatty acid supplements on AD. It
was not possible to pool these estimates of the effect of
fish intake on AD because of differences between studies
in the measure of exposure to fish, and the reporting of
results. For the purpose of the ANU-ADRI, individual
study questionnaires were reviewed to identify the most
suitable self-report questions that assess fish intake that
had been validated, and was freely available. Based on
this review the questions and odds ratios for fish con-
sumption were selected from the Cardiovascular Health
Study (Huang et al. 2005).
Cognitive Activity Cognitive activity was identified by
Williams et al. (2010) as a factor that reduced the risk of
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AD. Two large cohort studies reported a reduced risk of AD
in older adults who engage in cognitively stimulating activ-
ities (Akbaraly et al. 2009; Wilson et al. 2007). The odds
ratio for cognitive activity was calculated from these two
studies, with data obtained from authors for one study
(Wilson et al. 2007). (Forest plot included in online
supplement). Both studies used similar methodology to
evaluate exposure level. The questionnaire developed for
the Rush Memory and Aging Project has been used in
three studies by the same research group and has adequate
short-term temporal stability and internal consistency. It
was therefore chosen for inclusion in the ANU-ADRI;
however, items were adapted to include online cognitive
activities (e.g., accessing libraries online in addition to in
person).
Social Engagement Social engagement was identified by
the Williams report as protective against Alzheimer’s dis-
ease with results available from four large cohort studies
reporting effect sizes for social engagement (Bassuk et al.
1999; Fratiglioni et al. 2000; Helmer et al. 1999; Saczynski
et al. 2006). Two of these used similar measures (HAAS and
Kungsholmen) and data from these were pooled (see online
supplement) to obtain the odds ratios for the ANU-ADRI
(Fratiglioni et al. 2000; Saczynski et al. 2006). The social
network measure included marital status, size and quality of
social network, level of social activities and living arrange-
ments for both studies and the same measure was included
in the ANU-ADRI.
Occupational Exposure to Pesticide Occupational exposure
to pesticide as a risk factor for AD was identified in the
review by Williams et al. (2010). We identified an additional
article reporting an odds ratio for occupational pesticide
exposure (Baldi et al. 2003; Hayden et al. 2010; Tyas et al.
2001) and a pooled estimate was calculated based on these
(included in the online supplement). Questions were devel-
oped specifically for the ANU-ADRI.
Variables Not Included Several studies reported that coro-
nary artery disease was a risk factor for AD; however, this
factor was measured using incompatible methods and meta-
analysis of findings was not possible. There is still not
enough evidence to evaluate whether ischemic heart disease
(including myocardial infarction, angina, and stroke) is a
risk factor for AD. With respect to stroke it is difficult to
differentiate between AD and post-stroke vascular AD and
we did not find any systematic review that could clarify this
issue. There is still no firm evidence that hypertension is a
risk factor for AD according to the most recent meta-
analysis (Power et al. 2011). While ethnicity is included in
a previous dementia risk index (Reitz et al. 2010), there is no
meta-analysis of ethnicity and it is unknown whether this
finding generalizes to other studies or the population. We
identified no meta-analysis of self-reported family history
of AD based on prospective studies, despite one meta-
analysis of case control studies finding an association (van
Duijn et al. 1991).
Assumptions Made in the ANU-ADRI
Due to the limitations of available evidence specific
assumptions are made in the ANU-ADRI that will be eval-
uated in later versions as more data become available.
Assumptions are made about the equivalence for most risk
factors for males and females as few studies report odds
ratios for males distinct from females. Some assumptions
are made about the effect of some risk factors occurring at
ages younger than that observed in the studies from which
odds ratios were obtained. These assumptions were consid-
ered carefully based on available knowledge of the mecha-
nisms by which risk factors may affect AD. For example,
the systematic review of smoking included mostly studies of
older adults so that the odds ratios reported in Anstey et al.
(2007) apply to older adults but not middle-aged adults.
However, no age limit is specified for smoking in the ANU-
ADRI. This is because the ANU-ADRI is aimed to assess risk
of AD on the assumption that a person’s risk profile remained
constant until old age. (i.e., if an individual who smokes in
late-middle age does not give up smoking then their risk of
AD in old age will increase by 79 %). Assumptions were also
made in relation to the equivalence of clinical and self-report
measures of high cholesterol in order to apply the risk ratio
from studies using serum cholesterol to the self-report data on
high cholesterol. The additive nature of the algorithm devel-
oped to compute the ANU-ADRI assumes that the interac-
tions between risk factors are negligible. The analyses from
individual cohort studies reporting associations between risk
factors and AD adjust for covariates, which to some extent
controls for possible covariation. This assumption of additiv-
ity of risk factors can be tested when validation studies of the
ANU-ADRI are conducted.
Comparison with Previous AD Risk Assessment Tools
Reitz et al. (2010) focused on vascular risk factors for AD.
Of the 11 risk factors included in their AD risk score, 6
could be ascertained by self-report including age, sex, edu-
cation, ethnicity, diabetes, heart disease. The odds ratio for
diabetes was higher in this study than that derived from
meta-analyses and used in the ANU-ADR (2.04 vs 1.39).
This study did not find smoking significantly associated
with risk of AD but included ethnicity and heart disease
which are not included in the ANU-ADRI. Jessen et al.
found five variables predicted conversion to AD, three of
which could be assessed by self-report (age, memory
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complaint and difficulties with instrumental activities of
daily living). The latter two could be caused by AD and
hence are not necessarily independent risk factors.
Discussion
We report a new methodology for developing evidence-
based risk assessment tools focussing on the risk assessment
of AD. This method is comprehensive, and incorporates a
life-course perspective into risk assessment by allowing for
risk and protective factors to interact with age. We argue that
this evidence-based approach to risk assessment for a chron-
ic disease that is highly prevalent in late-life provides the
best foundation for prevention programs aimed at reducing
population-prevalence through targeted risk reduction. An
evidence-based risk assessment incorporating age-specific
effects may also be used to provide individual tailored
advice by primary care physicians in counselling patients.
We acknowledge that there is also a role for risk assessment
tools incorporating clinical measures that are predictive of
disease or indicative of pre-clinical dementia but this falls
outside the aims of the current study.
Our approach identified far more risk and protective
factors than previous studies that have developed risk
indices based on individual cohort studies. This increases
the utility of the instrument for use in population-based
primary prevention programs. It may be used to screen
individuals to identify those at high risk of AD who
would benefit most from intervention programs. The tool
may also be used as an outcome measure for randomized
controlled trials of AD risk reduction. The methodology
we have presented provides a framework for continual
updating and improving of the risk assessment. As more
studies are published, the odds ratios can be recalculated
and the scoring algorithm updated. As new risk and
protective factors are identified they can be added. This
methodology could be applied in other settings where
there is a need to develop population-level approaches to
prevention and incorporate information on risk factors that
varies over the life-course.
Biological mechanisms for most of the risk factors in-
cluded in the ANU-ADRI have been identified or else
biologically plausible pathways have been outlined and are
described elsewhere. For example, the proposed pathophys-
iological mechanisms underlying the role of diabetes in the
development of AD include endocrine, metabolic and vas-
cular abnormalities and dysfunctions (Biessels et al. 2006).
TBI is thought to increase the risk of AD by accelerating
amyloid deposition (Kidd 2008). The protective effect of
alcohol has been demonstrated in a mouse model and has
been attributed to the attenuation of β neuropathy following
alcohol consumption (Wang et al. 2006). The mechanisms
by which social and cognitive stimulation are thought to
reduce the risk of AD remain unknown but are thought to
involve neurogenesis resulting from neurostimulation
(Redolat and Mesa-Gresa 2011), and down regulation of
stress pathways (Rodriguez et al. 2011).
Our survey of the literature did not identify any study that
includes all the exposure variables measured by the ANU-
ADRI; hence, we expect that validation studies will under-
estimate the predictive validity of the index. This research
however may be used to guide the design of ongoing and
new cohort studies focusing in cognitive decline and de-
mentia as outcomes. Estimation of predictive validity from
existing datasets containing large numbers of risk and pro-
tective factors is the best method available to assess the
utility of the index, and to derive valid ranges on the index
that correspond to ‘low risk,’ ‘moderate risk’ and ‘high
risk’. External validation of the ANU-ADRI on three such
cohort studies is in progress.
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